John Haley - Maximus Independent Non-Executive Chairman of the Board
| MMS Stock | USD 73.46 0.37 0.51% |
Chairman
Mr. John J. Haley is an Independent Director of Maximus, Inc. Since January 2016, John J. Haley has served as one of our directors since 2002. Since January 2016, Mr. Haley has served as the Chief Executive Officer of Willis Towers Watson, an insurance broker and human resources and employee benefits consulting firm formed through the merger of Willis Group Holdings Public Limited Company and Towers Watson Co. From 2010 until January 2016, Mr. Haley served as the Chief Executive Officer and Chairman of the Board of Towers Watson Co. Previously he served as President and Chief Executive Officer of Watson Wyatt Worldwide, Inc. from 1999 until its merger with Towers Perrin, Forster Crosby, Inc. in 2010. Mr. Haley joined Watson Wyatt in 1977. Mr. Haley is a Fellow of the Society of Actuaries and is a coauthor of Fundamentals of Private Pensions . He has an A.B. in Mathematics from Rutgers College and studied under a Fellowship at the Graduate School of Mathematics at Yale University since 2021.
| Age | 71 |
| Tenure | 3 years |
| Address | 1600 Tysons Boulevard, McLean, VA, United States, 22102 |
| Phone | 703 251 8500 |
| Web | https://www.maximus.com |
John Haley Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Haley against Maximus stock is an integral part of due diligence when investing in Maximus. John Haley insider activity provides valuable insight into whether Maximus is net buyers or sellers over its current business cycle. Note, Maximus insiders must abide by specific rules, including filing SEC forms every time they buy or sell Maximus'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Haley over six months ago Acquisition by John Haley of 5885 shares of Maximus at 84.96 subject to Rule 16b-3 |
Maximus Management Efficiency
The company has Return on Asset of 0.075 % which means that on every $100 spent on assets, it made $0.075 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1701 %, implying that it generated $0.1701 on every 100 dollars invested. Maximus' management efficiency ratios could be used to measure how well Maximus manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Maximus' Return On Capital Employed is comparatively stable compared to the past year. Return On Assets is likely to gain to 0.12 in 2024, whereas Return On Tangible Assets are likely to drop 0.12 in 2024. At this time, Maximus' Debt To Assets are comparatively stable compared to the past year. Fixed Asset Turnover is likely to gain to 25.62 in 2024, whereas Deferred Long Term Asset Charges is likely to drop slightly above 1.2 M in 2024.Similar Executives
| Found 4 records | CHAIRMAN Age | ||
| Wangchun Ye | Oneconnect Financial Technology | 65 | |
| Joshua James | Domo Inc | 51 | |
| Geoffrey Barker | Smartsheet | 58 | |
| Carine Clark | Domo Inc | 60 | |
Management Performance
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.075 |
Maximus Leadership Team
Elected by the shareholders, the Maximus' board of directors comprises two types of representatives: Maximus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maximus. The board's role is to monitor Maximus' management team and ensure that shareholders' interests are well served. Maximus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maximus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruce Caswell, Pres and General Manager of Global Health Services | ||
| Elisabeth Schmidt, Senior Services | ||
| Derrick Pledger, Chief Officer | ||
| David Francis, General Counsel, Secretary | ||
| Peter Pond, Non-Executive Independent Chairman of the Board | ||
| John Lambeth, Chief Officer | ||
| Jessica Batt, VP ESG | ||
| Theresa Golinvaux, Senior Officer | ||
| Julia Bailey, Senior Compliance | ||
| Ilene Baylinson, General Manager, U.S. Services | ||
| Teresa Weipert, General Manager, U.S. Federal Services | ||
| Richard Montoni, Co-Vice Chairman and Senior Advisor to the Chief Executive Officer | ||
| John Martinez, General Officer | ||
| John Boyer, Chairman Foundation | ||
| Deborah Homewood, Managing Australia | ||
| Thomas Romeo, General Manager, U.S. Federal Services | ||
| Michael Warren, Independent Director | ||
| Gayathri Rajan, Independent Director | ||
| Jan Madsen, Independent Director | ||
| David Mutryn, Chief Financial Officer, Treasurer | ||
| Raymond Ruddy, Independent Vice Chairman of the Board | ||
| Anne Altman, Independent Co-Vice Chairman of the Board | ||
| Michelle Link, Chief Human Resource Officer | ||
| David CPA, CFO Treasurer | ||
| Mike Raker, Chief Officer | ||
| Eileen Rivera, Vice Relations | ||
| Jericho Seguin, Senior Planning | ||
| Richard Nadeau, Chief Financial Officer, Treasurer | ||
| John Haley, Independent Non-Executive Chairman of the Board |
Maximus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Maximus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.075 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 5.5 B | ||||
| Shares Outstanding | 60.3 M | ||||
| Shares Owned By Insiders | 0.99 % | ||||
| Shares Owned By Institutions | 99.73 % | ||||
| Number Of Shares Shorted | 773.2 K | ||||
| Price To Earning | 19.50 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Maximus Stock Analysis
When running Maximus' price analysis, check to measure Maximus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maximus is operating at the current time. Most of Maximus' value examination focuses on studying past and present price action to predict the probability of Maximus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maximus' price. Additionally, you may evaluate how the addition of Maximus to your portfolios can decrease your overall portfolio volatility.